Healthcare
Tevogen Bio Holdings Inc.(TVGN)
Live Price
Offline$10.60
-1.40% today
1Y Change
-82.55%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- $30.00M
- Revenue Growth
- 0.0%
- EPS Growth
- -72.6%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tevogen Bio Holdings Inc. (TVGN) is a Healthcare stock with a market cap of $30.00M and listed on NASDAQ. The stock last traded around $10.60 and down 82.5% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -72.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -72.6%, free cash flow -3.3% with operating margin 0.0% and ROIC 3698.7%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TVGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 15, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at 0.0% and EPS is at -72.6%, with operating margin around 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +19.2% over the next 5 trading days and finished higher after 3 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 15, 2026 | โ | +11.7% | +20.9% | โ |
2026 Mar 31, 2026 | +20.0% | -0.9% | +28.5% | +42.0% |
2025 Nov 14, 2025 | +50.7% | -7.2% | +8.2% | -4.6% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TVGN
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
TVGN Max Drawdown
-93.19%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for TVGN and SPY.
Company Overview
Tevogen Bio Holdings Inc.
NASDAQ Global Market
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
- Leadership
- Ryan H. Saadi
- IPO Date
- Jan 5, 2022
- Employees
- 18
- Street Address
- 15 Independence Blvd
- Mailing
- Warren, NJ, 07059
- Region
- Warren, NJ, US
- Reporting Currency
- USD
- Investor Line
- 877 838 6436
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- -72.6%
- Free Cash Flow
- -3.3%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 316.0%
- ROIC
- 3698.7%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.22
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.